Sort
10,766 grants matching “checkpoint inhibitor”
Targeted manipulation of the DNA damage response for prevention/treatment of GVHD
$198,750Michael Jordan · Cincinnati Childrens Hosp Med Ctr · R21 · FY2020 · AI
Project 1
$198,657Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2025 · CA
Project 2 - Joshua Hood, PhD
$198,466Joshua L. Hood · University Of Louisville · P20 · FY2025 · GM
Novel biologics platform for targeting tumors driven by intracellular oncoproteins
$198,103Shohei Koide · New York University School Of Medicine · R21 · FY2022 · CA
A germline variant that predicts and modulates the response of melanoma to immunotherapy
$198,103Iman Osman · New York University School Of Medicine · R21 · FY2017 · CA
Defining host-microbiota interactions during colorectal cancer and immune checkpoint blockade
$198,103Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R21 · FY2020 · CA
Tetraacylated lipid A enhancement of checkpoint blocking cancer immunotherapy
$198,103Dennis L. Kasper · Harvard Medical School · R21 · FY2025 · CA
DISSECTING THE ROLE OF THE IMMUNE MICROENVIRONMENT IN MELANOMA BONE METASTASIS
$198,103Eva Hernando · New York University School Of Medicine · R21 · FY2025 · CA
Augmenting cancer checkpoint immunotherapies via microbially-derived metabolites
$198,018Matthew Everett Griffin · University Of California-Irvine · K22 · FY2023 · CA
Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence
$197,856Michael T Lewis · University Of Utah · U54 · FY2023 · CA
Dissecting the interactions between TCR signaling strength and inhibitory pathways
$197,748Lin Shen · University Of California, San Francisco · K08 · FY2022 · AI
Proteasome subunit beta5t and thymus-specific peptides in T cell selection
$197,656John J. Monaco · University Of Cincinnati · R21 · FY2015 · AI
Deciphering interactions between human T cells and cardiomyocytes in immune checkpoint inhibitor-related myocarditis
$197,640Steven Blum · Massachusetts General Hospital · K08 · FY2025 · AI
A prognostic mRNA immune signature for resected stage II-III melanoma
$197,614Yvonne Margaret Saenger · Columbia University Health Sciences · UH2 · FY2019 · CA
Targeting the Androgen Receptor to Sensitize Bladder Cancer to Immune Check Point Blockade.
$197,519David Mulholland · Icahn School Of Medicine At Mount Sinai · R21 · FY2025 · CA
Exploring potential biomarkers predictive of response to ATR and CHK1 inhibitors
$197,472Junran Zhang · Ohio State University · R21 · FY2019 · CA
INHIBITORS OF CYCLIN DEPENDENT KINASES
$197,196University Of South Florida · P01 · FY2001 · CA
INHIBITORS OF CYCLIN DEPENDENT KINASES
$197,196University Of South Florida · P01 · FY2002 · CA
SMART ASSAYS FOR LIGANDS TO STUDY AND TREAT CANCER
$197,079Harvard University (Medical School) · P01 · FY2002 · CA
Translation of commensal bacteria mechanism for immunotherapy
$196,992Howard C Hang · Rockefeller University · R01 · FY2021 · CA
Single-Cell Transcriptome & Effect of Immune Checkpoint Therapy on Kaposi Sarcoma
$196,875Lee Ratner · Washington University · R21 · FY2021 · CA
Multifunctional Nanoprobe for Early Appraisal of Immunotherapeutic Efficacy
$196,875Srikanth Singamaneni · Washington University · R21 · FY2022 · EB
Cancer Center Support Grant
$196,875Michael A Teitell · University Of California Los Angeles · P30 · FY2025 · CA
Tumor-targeted disruption of mismatch repair in microsatellite stable colorectal cancer
$196,525Judy Lieberman · Boston Children'S Hospital · R21 · FY2024 · CA
MECHANISMS OF HEV CELL RECOGNITION OF APOPTOTIC CELLS
$196,484University Of Cincinnati · R01 · FY2000 · AI